2023Cochrane Database of Systematic ReviewsRequires access

De novo mTOR inhibitor immunosuppression versus calcineurin inhibitor immunosuppression for liver transplant recipients

Sophie Kollbeck, Julia‐Kristin Graß, Jens Hillingsø, Luit Penninga

Open publisher page 0 citations

Abstract

Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of de novo mTOR inhibitor‐based versus calcineurin inhibitor‐based immunosuppression for liver transplant recipients.

About this research paper

What this paper is about

Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of de novo mTOR inhibitor‐based versus calcineurin inhibitor‐based immunosuppression for liver transplant recipients.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of de novo mTOR inhibitor‐based versus calcineurin inhibitor‐based immunosuppression for liver transplant recipients.

Key concepts: Immunosuppression, Calcineurin, Discovery and development of mTOR inhibitors, Medicine, Liver transplantation, Sirolimus, PI3K/AKT/mTOR pathway, Tacrolimus

Related papers

Back to paper searchBrowse research topicsOriginal source
De novo mTOR inhibitor immunosuppression versus calcineurin inhibitor immunosuppression for liver transplant recipients — Research Paper | ScholarLens